Core Laboratories N.V. (CLB) — Fair Value Analysis

Base-case fair value (P50): $12.05 · Current price: $12.45 · Verdict: Fairly Valued

The Verdict on CLB

Based on our latest Monte Carlo simulations, CORE LABORATORIES INC (CLB) appears to be Fairly Valued. The stock's current market price of $12.45 is closely aligned with our median fair value estimate (P50) of $12.05. This indicates a marginal -3.2%, suggesting that CLB's current valuation reflects its intrinsic worth as determined by our forward-looking model. Investors should note this tight alignment between the market and our probability-weighted fair value, derived from thousands of simulated future scenarios.

How CLB stacks up against peers

While CLB operates in the n/a sector, our analysis positions its operational and financial health as an "average" quality tier. This assessment suggests that CLB holds a stable, but not outstanding, competitive position relative to its peers. The tight convergence of its $12.45 and $12.05 reflects this average quality, implying that the market has accurately priced CLB given its fundamental characteristics and expected performance within its industry. There isn't a significant disconnect that would point to either substantial undervaluation or overvaluation at this time based on our median estimate.

What this means for investors

For investors considering CLB, the "Fairly Valued" verdict, coupled with the -3.2%, points to limited immediate arbitrage opportunity based on our median fair value. While the stock may not offer a compelling deep-value entry or an obvious short candidate today, its stable valuation, as reflected by the $12.45 versus $12.05, provides a clear benchmark. Understanding the full probability distribution, including potential downside and bull case scenarios, is crucial for a complete picture. Sign up for a free FairCurve account to see the full bear/bull distribution and track CLB's fair value as new fundamentals are released.